Slingshot members are tracking this event:
Ixekizumab Demonstrates High Levels of Skin Clearance among Patients with Moderate-to-Severe Plaque Psoriasis Who Did Not Respond to Treatment with Etanercept
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Mar 07, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Ixekizumab, Skin Lesions, Plaque Psoriasis, Etanercept, Phase 3 Data, Uncover-2